Striking leflunomide efficacy against refractory cutaneous sarcoidosis Gérôme Bohelay, MD, Jean-David Bouaziz, MD, PhD, Hilario Nunes, MD, PhD, Michel Rybojad, MD, Martine Bagot, MD, PhD, Antoine Petit, MD, Liliane Laroche, MD, PhD Journal of the American Academy of Dermatology Volume 70, Issue 5, Pages e111-e113 (May 2014) DOI: 10.1016/j.jaad.2013.10.048 Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 A, Sarcoidosis skin lesions on the right cheek in patient 1 before leflunomide treatment. B, Complete remission in patient 1 after 12 months of leflunomide treatment. Journal of the American Academy of Dermatology 2014 70, e111-e113DOI: (10.1016/j.jaad.2013.10.048) Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 A, Severe facial lupus pernio in patient 2 before combined leflunomide and methotrexate treatment. B, Rapid partial response of the facial lupus pernio in patient 2 after 4 months of combined leflunomide and methotrexate treatment. Journal of the American Academy of Dermatology 2014 70, e111-e113DOI: (10.1016/j.jaad.2013.10.048) Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions